Clinical Trials
19 trialsNCT05254119 2024-04-04
REGISTURK-LUNG
Oncological Clinical Research Association, Turkey
Unknown
NCT05991180 2023-12-27
Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT05873790 2023-05-24
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
The First Hospital of Jilin University
Unknown
NCT05826756 2023-04-28
PEER
LUNGevity Foundation
Unknown
NCT05769504 2023-04-03
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
Power Life Sciences Inc.
Unknown
NCT05761977 2023-03-09
DRIVE
Hellenic Cooperative Oncology Group
Unknown
NCT04947774 2021-09-22
Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer
ChineseAMS
Unknown
NCT04790955 2021-03-10
Effect of Combination Therapy on SCLC After Initial Treatment Failure
First Affiliated Hospital of Harbin Medical University
Unknown
NCT04672759 2020-12-17
A Real-world Study of Durvalumab for Lung Cancer in China
Peking Union Medical College Hospital
Unknown
NCT04663438 2020-12-11
Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC
Peking Union Medical College Hospital
Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT04440800 2020-06-22
WATTOX
Royal Marsden NHS Foundation Trust
Unknown
NCT03162705 2019-01-22
MPSCLC
Zhujiang Hospital
Unknown
NCT02577627 2017-04-04
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
Optimata Ltd.
Unknown
NCT03029858 2017-01-24
ATHENE
Guangdong Association of Clinical Trials
Unknown
NCT00693836 2013-08-12
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
National Cancer Institute (NCI)
Unknown
NCT00503958 2013-05-15
Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer
National Cancer Institute (NCI)
Unknown
NCT01752517 2012-12-19
Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer
Peking Union Medical College Hospital
Unknown
NCT00418743 2010-03-09
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
Groupe Francais De Pneumo-Cancerologie
Unknown